Krajcer Zvonimir, Ramaiah Venkatesh G, Huetter Meredith, Miller Larry E
St. Luke's Episcopal Hospital, Houston, Texas.
Arizona Heart Institute, Phoenix, Arizona.
Catheter Cardiovasc Interv. 2016 Dec;88(7):1118-1123. doi: 10.1002/ccd.26626. Epub 2016 Jul 12.
To assess the feasibility, safety, and clinical utility of a fast-track endovascular aneurysm repair (EVAR) protocol.
Despite recent advances in EVAR technology and techniques, considerable opportunity exists to further improve EVAR efficiency and outcomes.
Eligible patients underwent elective EVAR with the Ovation Prime stent graft. Successful completion of the fast-track protocol required bilateral percutaneous access, avoidance of general anesthesia and intensive care unit admission, and next-day discharge. Patients were followed through 1-month post-treatment.
Between October 2014 and September 2015, 129 patients were enrolled in the study. Vascular access, stent graft delivery, and stent graft deployment were successful in all patients. The fast-track EVAR protocol was successfully completed in 114 (88%) patients. Bilateral percutaneous access was achieved in 97% of cases. Comparing patients who completed fast-track requirements to those who failed at least one component, procedure time was 86 vs. 122 min, use of general anesthesia was 0% vs. 20%, need for intensive care unit stay was 0% vs. 13%, hospital stay was 1.1 vs. 2.1 days, and postoperative groin pain severity (0-10 scale) was 1.2 vs. 4.0. No type I or III endoleaks, serious device-related adverse events, AAA ruptures, surgical conversions, or AAA-related secondary procedures were reported. One (0.9%) patient in the fast-track group died from acute respiratory failure.
Initial results from the LIFE study are encouraging and suggest that a fast-track protocol is feasible, safe, and may improve efficiency of healthcare resource allocation in select patients undergoing EVAR. © 2016 Wiley Periodicals, Inc.
评估快速血管内动脉瘤修复(EVAR)方案的可行性、安全性及临床实用性。
尽管EVAR技术和技巧近期有所进展,但仍有很大机会进一步提高EVAR的效率和治疗效果。
符合条件的患者接受使用Ovation Prime覆膜支架的择期EVAR治疗。成功完成快速方案要求双侧经皮穿刺入路、避免全身麻醉和入住重症监护病房,并于次日出院。对患者进行随访直至治疗后1个月。
2014年10月至2015年9月期间,129例患者纳入研究。所有患者血管穿刺、覆膜支架输送及覆膜支架释放均成功。114例(88%)患者成功完成快速EVAR方案。97%的病例实现双侧经皮穿刺入路。将完成快速方案要求的患者与至少一项未达标的患者进行比较,手术时间分别为86分钟和122分钟,全身麻醉使用率分别为0%和20%,入住重症监护病房的需求分别为0%和13%,住院时间分别为1.1天和2.1天,术后腹股沟疼痛严重程度(0 - 10分)分别为1.2分和4.0分。未报告I型或III型内漏、严重的与器械相关的不良事件、AAA破裂、手术中转或与AAA相关的二次手术。快速组中有1例(0.9%)患者死于急性呼吸衰竭。
LIFE研究的初步结果令人鼓舞,表明快速方案可行、安全,且可能提高接受EVAR的特定患者的医疗资源分配效率。© 2016威利期刊公司